Podcast

February 24, 2026

227 – When Should You Open a CAPA? Triggers, Human Error, and Investigation Basics

Subhi Saadeh sits down with Georg Digel, founder of Elevate CAPA, to break down what should trigger CAPA, and how to investigate the right way using practical tools and better

February 18, 2026

226 – Navigating China NMPA Medical Device Requirements | Standards, GMP Updates, Agents & Classification

In this episode, Subhi Saadeh sits down with Elaine (Yi Ling Tan), Creator and Principal Consultant at MedTech Chopsticks, to break down China medical device market access and regulatory compliance

February 11, 2026

226 – ICH Q4 Explained: How Pharmacopeial Methods Are Accepted Across Regions

In this episode of the ICH Q series, Subhi Saadeh covers ICH Q4, which focuses on pharmacopeial harmonization. He explains why ICH Q4 exists, the problem it was created to

February 4, 2026

225 – ICH Q3A, Q3B, Q3C, Q3D and Q3E – EXPLAINED in 10 Minutes

In this episode of Let’s ComBinate: Drugs + Devices, host Subhi Saadeh breaks down ICH Q3, the family of guidelines that define how impurities are identified, evaluated, and controlled in

January 28, 2026

224 – ICH Q2 Explained: What Analytical Validation Really Requires

In this episode of Let’s Combinate, host Subhi Saadeh breaks down the ICH Q2 guideline with a practical focus on analytical procedure validation. The discussion covers key definitions, core validation

January 21, 2026

223 – What’s Changing in ICH Q1 and What Isn’t: Understanding Stability Expectations

In this episode of Let’s Combinate: Drugs and Devices, host Subhi Saadeh breaks down the 2025 draft update to the ICH Q1 guideline and explains what has actually changed and

January 14, 2026

222 – How ICH Guidelines Are Organized: Understanding the Q, S, E, and M Series

In this episode of Let’s Combinate: Drugs + Devices, host Subhi Saadeh continues the Combinating with ICH series by breaking down how the International Council for Harmonisation (ICH) guidelines are

January 7, 2026

221 – What Is ICH and Why It Matters

In this episode of Let’s Combinate: Drugs + Devices, Subhi Saadeh kicks off a new series focused on the International Council for Harmonisation (ICH) and its impact on drug and

December 31, 2025

220 – Managing Oneself, Reflections and a New Series on ICH

???? Stay ahead in combination products, pharma, and medical devices ???? https://www.letscombinate.com ????️ Listen to more expert discussions on regulations, drug delivery, and quality ???? https://www.letscombinate.com/ Get expert insights on

December 24, 2025

219 – FDA PreCheck and the Future of Inspections: PAI to Pre-Readiness

In this episode of Let’s Combinate: Drugs + Devices, host Subhi Saadeh is joined by Ben Locwin to break down what’s changing in FDA pre-approval and pre-license inspections—and why the

December 17, 2025

218 – ICH Q13: Continuous Manufacturing EXPLAINED (Batch vs. Continuous)

In this short episode of Let’s Combinate: Drugs + Devices, Subhi Saadeh breaks down ICH Q13 and what “continuous manufacturing” actually means. He compares batch vs. continuous, explains how a

December 10, 2025

217 – 5 Fixable Problems Holding Back Drug–Device Programs

In this episode of Let's Combinate: Drugs + Devices, host Subhi Saadeh addresses five significant quality issues in the combination product space. This episode provides practical insights and strategies for

Join Our newsletter

Sign up now to stay ahead with our combo product tips and never miss a weekly episode!

By signing up, you agree to receive email from this website.